What does this research mean for the field?

Repetitive transcranial magnetic stimulation (rTMS) is a safe and adaptable therapeutic option for managing tinnitus, particularly in patients with comorbid mood disturbances. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The primary aim is to outline an effective rTMS protocol for managing tinnitus symptoms.

March 10, 2026Open Access

Repetitive Transcranial Magnetic Stimulation Protocol for Tinnitus Patients

Puntos clave

The primary aim is to outline an effective rTMS protocol for managing tinnitus symptoms.
Applied rTMS to the left or contralateral auditory cortex
Used a standard protocol of 1 Hz stimulation at 100%-110% resting motor threshold
Delivered 1800-2000 pulses per session over 10 consecutive treatment days
In select patients, additional stimulation targeted the left dorsolateral prefrontal cortex
Demonstrated the feasibility of the rTMS protocol in clinical settings
Indicated safety and adaptability of rTMS for managing tinnitus
Noted potential improvements in patients with comorbid affective symptoms

Resumen

Tinnitus, defined as the perception of sound without an external source, can be particularly distressing when persistent.Among various treatment approaches, repetitive transcranial magnetic stimulation (rTMS) has gained attention as a non-invasive method for modulating maladaptive neuroplastic changes, specifically the hyperactivity and aberrant neural synchrony observed in the auditory cortex (AC) of patients with chronic tinnitus.This report outlines a practical rTMS protocol currently used in clinical settings for tinnitus management.The standard protocol consisted of 1 Hz stimulation at 100%-110% of the resting motor threshold (rMT), applied to the left or contralateral AC, delivering 1800-2000 pulses per session across 10 consecutive treatment days.In selected patients, adjunct excitatory stimulation was delivered to the left dorsolateral prefrontal cortex, especially in cases with comorbid affective symptoms.rTMS offers a safe, adaptable therapeutic option, particularly for patients with concurrent mood disturbances.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Ho Yun Lee (Wed,) studied this question.

synapsesocial.com/papers/69af944f70916d39fea4b4e3 https://doi.org/https://doi.org/10.3342/kjorl-hns.2025.00402

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Me gusta

Guardar

Ver artículo completo